Zelira Hope 1 is owned by Zelira Therapeutics, that focuses on advancing the company's lead cannabinoid-based drug candidate.
Zelira Hope 1 has raised $33.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Zelira Hope 1's investors include ThirdGate Capital Management.
Zelira Hope 1 is headquartered in Perth, Australia.
Zelira Hope 1 is owned by Zelira Therapeutics, that focuses on advancing the company's lead cannabinoid-based drug candidate.
Zelira Hope 1 is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zelira Hope 1 — Funding & Investors." VCBacked, January 16, 2026, https://www.vcbacked.co/company/zelira-hope-1. Accessed August 16, 2026.
VCBacked. (2026). Zelira Hope 1 — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/zelira-hope-1
{{cite web |title=Zelira Hope 1 — Funding & Investors |url=https://www.vcbacked.co/company/zelira-hope-1 |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated